Analysis mechanism of CD19- relapse in CARPALL study
Whole exome sequencing of CD19- relapses in CARPALL study
- 10 samples
- DAC: EGAC00001001257
- Technology: Illumina HiSeq 3000
DAC for Analysis of mechanisms of CD19- relapse in CARPALL study: EGAC00001001257 ena-DAC-UCL-ICH-26-06-2019-22:34:34:991-190
European Genome-phenome Archive 26th June 2019 European Bioinformatics Institute Great Ormond Street Hospital & European Molecular Biology Laboratory UCL Institute of Child Health Wellcome Trust Genome Campus 30 Guilford Street Hinxton, Cambridge, CB10 1SD London, WC1N 1EH United Kingdom United Kingdom DAC for Analysis of mechanisms of CD19- relapse in CARPALL study: EGAC00001001257 ena-DAC-UCL-ICH-26-06-2019-22:34:34:991-190 This document specifies the policy for granting access to the European Genome-phenome Archive (EGA) secure Web based tools for managing data access permissions to the data stored in the EGA database. Access is granted to those Data Access Committee members named in this document by Paul Flicek, head of Genes, Genomes and Variation. Conditions of access: The account holder will abide by all current and future policies of the EBI for computer use as well as computer use policies of the European Molecular Biology Laboratory (EMBL), of which the EBI is a part. All EGA specific policies and standard operating procedures (SOPs) must also be followed. All applicable policies will be provided to the authorized users. Method of access: The EBI will create a personal account for the authorized person. The account username and password together with a RSA key provide access to the secure EGA infrastructure. A separate document with detailed guidelines on how to access and use these tools is provided to each account holder. The EGA help-desk provides training when needed. Review: All individuals will access to the EGA user authorization tools will be reviewed annually by Paul Flicek. Any staff changes affecting the authorized person must be provided immediately to Paul Flicek (flicek@ebi.ac.uk). Authorized Data Access Committee user: Dr Jack Bartram Level 2, Camelia Botnar lab, Room P2.007, Great Ormond Street Hospital UCL Institute of Child Health, London j.bartram@ucl.ac.uk; jack.bartram@gosh.nhs.uk Mr Tony Brooks UCL genomics, Level 2, Camelia Botnar lab, UCL Institute of Child Health, London a.brooks@ucl.ac.uk Signature of authorized user indicating that this policy has been read and understood. Supervisor of Authorized user: Professor Persis Amrolia Professor of Transplantation Immunology Persis.amrolia@gosh.nhs.uk Signature supervisor of authorized user indicating that this policy has been read and understood
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001003733 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.